Besides the analysis of the activated protein signaling, certain subgroups found from metastases share the same features such that AKT, ERK, ERBB4/HER4, and downstream substrates and mTOR in NSCLC are relatively activated. Here, ERBB4 is linked to non-small cell lung carcinoma.